On December 1, the FDA approved evolocumab (Repatha, Amgen) for the prevention of heart attack, stroke, and coronary revascularization in adults with established cardiovascular disease (CVD), as well as for the treatment of adults with primary hyperlipidemia to decrease LDL-C. This is in addition to the original approval … VIEW ARTICLE
The FH Community in Action is made up of individuals with FH and the medical professionals who treat them. Through the FH Foundation, we work together to raise awareness, support our members, drive research, and advocate for improved diagnosis and care.
Join us to help drive the change you want to see for families … VIEW ARTICLE
For a successful treatment of elevated cholesterol, it is important to maintain a healthy diet in combination with the right medications as well as a good exercise program.
For this to be successful, some attention should be put in selecting the right modality of exercise, and how to make it fun, sustainable, and … VIEW ARTICLE